Phalen Michael P. 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Phalen Michael P.
SVP & President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2018-02-28+5,413→ 134,423 total - Exercise/Conversion
Common Stock
2018-02-28+2,443→ 136,866 total - Tax Payment
Common Stock
2018-02-28$27.26/sh−3,493$95,219→ 133,373 total - Exercise/Conversion
Deferred Stock Units
2018-02-28−2,443→ 9,776 totalExp: 2022-02-28→ Common Stock (2,443 underlying) - Exercise/Conversion
Deferred Stock Units
2018-02-28−5,413→ 0 total→ Common Stock (5,413 underlying)
Footnotes (4)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.